Sequenom Announces Changes In Company Leadership
"It has been a pleasure to lead such a talented and innovative team at Sequenom.
Why Sequenom (SQNM) Closed Lower on Friday
By market close, shares had taken off 7.8% to $2.37. Trading volume of 4.25 million was more than double its three-month daily average.
Sequenom's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Good afternoon everyone, and welcome to Sequenom Fourth Quarter and Year End 2013 Financial Results Conference Call.
Sequenom Inc - 10-K - Management's Discussion and Analysis of...
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and the notes to such statements included elsewhere in this report.
Illumina DNA Screen for Down Syndrome Found More Accurate
Genetic screening for Down syndrome and Edwards syndrome using technology from Illumina Inc. provided a more accurate diagnosis than traditional techniques in a company-funded study.
Sequenom Inc. Announces Date Of Fourth Quarter And Full Year 2013...
Please use code 3696874. If you are unable to listen to the live webcast, a teleconference replay will be available through .
Prenatal Testing Firms Take IP Fight to Federal Circuit
Trouble is brewing for Sequenom as the biotech company tries to revive a prenatal testing patent that U.S. District Judge Susan Illston pronounced dead last fall.